Pharma Plant & Premises (As per Schedule M) A pharmaceutical facility’s plant and premises form the backbone of GMP compliance. Schedule M (India) lays down clear requirements to ensure that buildings, layouts, and utilities consistently support product quality, patient safety,…
Decoding Warehouse – Chapter 2: Risk Assessment of De-Dusting Tunnel This chapter focuses on systematic risk assessment of the de-dusting tunnel used in pharmaceutical warehouses for cleaning and de-dusting shipper cartons, drums, and containers before they enter controlled areas. It…
De-Dusting Tunnel in Pharmaceutical Warehouse A de-dusting tunnel in a pharmaceutical warehouse is a controlled system designed to remove loose dust, dirt, and external contamination from shipper cartons, drums, and other outer containers before they enter classified or controlled areas.…
Risk assessment for autoclave validation is a systematic process used to identify, evaluate, and control potential risks that could affect the sterilization performance and product quality. It ensures that the autoclave consistently achieves the required sterilization conditions (temperature, pressure, and…
Risk Assessment for Relocation of Compression Machine Relocating a tablet compression machine within a pharmaceutical facility is not a simple shifting activity – it is a GMP-critical change that can impact product quality, equipment performance, and compliance. A structured risk…
INTRODUCTION: Maintaining a contamination-free environment is essential in a microbiology laboratory, especially in pharmaceutical and healthcare settings where microbial control is critical. The Single Door Entry system is a fundamental architectural and procedural design element aimed at ensuring controlled access,…
A Computer System Validation (CSV) Master Plan is a high-level document that defines the overall approach, strategy, and methodology for validating computer systems in a pharmaceutical or GMP-regulated environment. It ensures that all computerized systems are fit for their intended…
The presence of glass particles in ampoules is a critical quality concern in the manufacturing of injectable pharmaceutical products. Glass particles, even in minute quantities, pose serious risks to patient safety, including the potential for embolism, tissue irritation, or systemic…
Introduction: Monthly Review Meetings (MRMs) are a cornerstone of an effective Quality Management System (QMS) within pharmaceutical manufacturing and other GMP-regulated environments. These structured meetings serve as a formal platform for cross-functional teams to review critical quality metrics, discuss ongoing…
“Loading pattern” in injectables (sterile manufacturing) refers to the validated arrangement of materials (vials, ampoules, syringes, stoppers, etc.) in cleanroom areas, especially inside laminar airflow (LAF) hoods, isolators, autoclaves, depyrogenation tunnels, and during aseptic filling operations. A proper loading pattern…